Trial Profile
Effect of ruxolitinib when given before allogeneic stem cell transplant in patients with myelofibrosis
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 04 Sep 2019
Price :
$35
*
At a glance
- Drugs Ruxolitinib (Primary)
- Indications Myelofibrosis
- Focus Adverse reactions; Therapeutic Use
- 28 Apr 2015 New trial record